Search research articles
Contact Us
Filters
Showing results (11-20 of 113) with videos related to
Page
of 12
Sort By:
Journal of Racial and Ethnic Health Disparities
|
July 1, 2018
Racial, Socioeconomic, and Geographic Disparities in the Receipt, Timing to Initiation, and Duration of Adjuvant Androgen Deprivation Therapy in Men with Prostate Cancer
Chi Nguyen, David R Lairson, Michael D Swartz, et al.
Population Health Management
|
August 27, 2016
The Immediate Impact of the 2009 USPSTF Screening Guideline Change on Physician Recommendation of a Screening Mammogram: Findings from a National Ambulatory and Medical Care Survey-Based Study
Suja S Rajan, Manasi S Suryavanshi, Siddharth Karanth, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 24, 2012
Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer
Kavita R Sail, Luisa Franzini, David R Lairson, et al.
American Journal of Therapeutics
|
December 26, 2013
Geographic Variation in Oxaliplatin Chemotherapy and Survival in Patients With Colon Cancer
Janki M Panchal, David R Lairson, Wenyaw Chan, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 31, 2019
Cost-Effectiveness of Adding Androgen Deprivation Therapy to Radiation Therapy for Men with Advanced Prostate Cancer from a U.S. Payer's Perspective
Chi Nguyen, David R Lairson, Michael D Swartz, et al.
Plos One
|
August 19, 2015
The Effect of National Cancer Screening on Disparity Reduction in Cancer Stage at Diagnosis by Income Level
Hye-Min Jung, Jin-Seok Lee, David R Lairson, et al.
Clinical Colorectal Cancer
|
November 10, 2012
Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer
Janki M Panchal, David R Lairson, Wenyaw Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort
Xianglin L Du, David R Lairson, Charles E Begley, et al.
Pharmacotherapy
|
August 7, 2018
Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer
Chi Nguyen, David R Lairson, Michael D Swartz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 29, 2004
Cost-effectiveness analysis of interventions to enhance mammography compliance using computer modeling (CAN*TROL)
Jasmanda H Wu, Man C Fung, Wenyaw Chan, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 113) with videos related to
Sort By:
Page
of 12
Journal of Racial and Ethnic Health Disparities
|
July 1, 2018
Racial, Socioeconomic, and Geographic Disparities in the Receipt, Timing to Initiation, and Duration of Adjuvant Androgen Deprivation Therapy in Men with Prostate Cancer
Chi Nguyen, David R Lairson, Michael D Swartz, et al.
Population Health Management
|
August 27, 2016
The Immediate Impact of the 2009 USPSTF Screening Guideline Change on Physician Recommendation of a Screening Mammogram: Findings from a National Ambulatory and Medical Care Survey-Based Study
Suja S Rajan, Manasi S Suryavanshi, Siddharth Karanth, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 24, 2012
Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer
Kavita R Sail, Luisa Franzini, David R Lairson, et al.
American Journal of Therapeutics
|
December 26, 2013
Geographic Variation in Oxaliplatin Chemotherapy and Survival in Patients With Colon Cancer
Janki M Panchal, David R Lairson, Wenyaw Chan, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 31, 2019
Cost-Effectiveness of Adding Androgen Deprivation Therapy to Radiation Therapy for Men with Advanced Prostate Cancer from a U.S. Payer's Perspective
Chi Nguyen, David R Lairson, Michael D Swartz, et al.
Plos One
|
August 19, 2015
The Effect of National Cancer Screening on Disparity Reduction in Cancer Stage at Diagnosis by Income Level
Hye-Min Jung, Jin-Seok Lee, David R Lairson, et al.
Clinical Colorectal Cancer
|
November 10, 2012
Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer
Janki M Panchal, David R Lairson, Wenyaw Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort
Xianglin L Du, David R Lairson, Charles E Begley, et al.
Pharmacotherapy
|
August 7, 2018
Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer
Chi Nguyen, David R Lairson, Michael D Swartz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 29, 2004
Cost-effectiveness analysis of interventions to enhance mammography compliance using computer modeling (CAN*TROL)
Jasmanda H Wu, Man C Fung, Wenyaw Chan, et al.
Page
of 12